دورية أكاديمية
Complications and Healthcare Costs Associated With the First Year Following Colostomy and Ileostomy Formation: A Retrospective Study.
| العنوان: | Complications and Healthcare Costs Associated With the First Year Following Colostomy and Ileostomy Formation: A Retrospective Study. |
|---|---|
| المؤلفون: | Brady RRW; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Scott J; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Grieveson S; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Aibibula M; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Cawson M; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Marks T; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Page J; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Artignan A; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Boisen EB; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark. |
| المصدر: | Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society [J Wound Ostomy Continence Nurs] 2023 Nov-Dec 01; Vol. 50 (6), pp. 475-483. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Mosby-Year Book Country of Publication: United States NLM ID: 9435679 Publication Model: Print Cited Medium: Internet ISSN: 1528-3976 (Electronic) Linking ISSN: 10715754 NLM ISO Abbreviation: J Wound Ostomy Continence Nurs |
| أسماء مطبوعة: | Original Publication: St. Louis, MO : Mosby-Year Book, c1994- |
| مواضيع طبية MeSH: | Colostomy*/adverse effects , Ostomy*/adverse effects, Humans ; Ileostomy/adverse effects ; Retrospective Studies ; State Medicine ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Health Care Costs |
| مستخلص: | Purpose: The purpose of this study was to evaluate clinical and economic outcomes during the first year following ostomy formation. Design: Single-center retrospective audit. Subjects and Setting: The sample comprised 200 patients who underwent surgery leading to ileostomy or colostomy at a large English National Health Service (NHS) Trust. Methods: Clinical complications, medicine prescriptions, and interactions with healthcare services were reported over 12 months postsurgery, and interactions with the NHS were matched to the closest NHS unit cost to determine mean patient cost. Results: The most common ostomy-related surgical site complications were high output (35.0%; n = 70), followed by moderate/severe peristomal skin complications (24.5%; n = 49) and bleeding (23.5%; n = 47). Ostomy management-related complications included general difficulties with ostomy management (50.0%; n = 100) and leakage-related mild peristomal skin issues (48.5%; n = 97). Clinical complication rates were highest in the first quarter following ostomy formation, except parastomal hernia, which increased in incidence over time. Ileostomy patients more frequently experienced high output, acute renal failure, and ostomy management-related complications and had increased length of inpatient admission. However, healthcare resource use was high in both groups, with a median of 13 inpatient admission days and 12 outpatient contacts overall within the first year. Mean cost per patient was £20,444.60 (US $26,018.41); 90.5% of these costs were attributed to ostomy-related factors. Conclusions: Patients are likely to experience at least one clinical complication following intestinal ostomy formation and have multiple interactions with the NHS. While a number of complications are more frequent in patients with ileostomies, both groups experienced considerable costs within the first year following surgery associated with ostomy management and recovery. Competing Interests: Conflicts of Interest: R.B. has received consultancy fees from a number of ostomy device manufacturers, including Coloplast. Newcastle Hospitals/Newcastle Centre for Bowel Disease Research Group has received research grants and income from Coloplast in support of research delivery as part of the center's long-term Stoma Research Programme. E.B.B., M.A., and M.C. are Coloplast Ltd employees. A.A., J.P., and T.M. are Costello Medical Ltd employees, whose support was funded by Coloplast Ltd. (Copyright © 2023 by the Wound, Ostomy and Continence Nurses Society.) |
| References: | NHS Digital. Hospital admitted patient care activity 2020-21. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2020-21 . Accessed August 8, 2022. NHS Inform. Ileostomy. https://www.nhsinform.scot/tests-and-treatments/surgical-procedures/ileostomy . Accessed September 5, 2022. NHS Inform. Colostomy. https://www.nhsinform.scot/tests-and-treatments/surgical-procedures/colostomy . Accessed September 5, 2022. East of England NHS Collaborative Procurement Hub. StoMap Programme baseline report 2019. https://www.eoecph.nhs.uk/Files/Integrated%20Care/StoMap%20Baseline%20Report%20FINAL.pdf . Accessed August 9, 2022. Colostomy UK. Step Up for Stomas 2021. https://www.colostomyuk.org/active-ostomates/step-up-for-stomas . Accessed August 8, 2022. Malik T, Lee M, Harikrishnan A. The incidence of stoma related morbidity—a systematic review of randomised controlled trials. Ann R Coll Surg Engl. 2018;100(7):501–508. Persson E, Berndtsson I, Carlsson E, Hallén AM, Lindholm E. Stoma-related complications and stoma size—a 2-year follow-up. Colorectal Dis. 2010;12(10):971–976. Formijne Jonkers HA, Draaisma WA, Roskott AM, van Overbeeke AJ, Broeders IA, Consten EC. Early complications after stoma formation: a prospective cohort study in 100 patients with 1-year follow-up. Int J Colorectal Dis. 2012;27(8):1095–1099. doi:10.1007/s00384-012-1413-y. Pearson R, Knight SR, Ng JC, Robertson I, McKenzie C, Macdonald AM. Stoma-related complications following ostomy surgery in 3 acute care hospitals: a cohort study. J Wound Ostomy Continence Nurs. 2020;47(1):32–38. Robertson I, Leung E, Hughes D, et al. Prospective analysis of stoma-related complications. Colorectal Dis. 2005;7(3):279–285. doi:10.1111/j.1463-1318.2005.00785.x. Taneja C, Netsch D, Rolstad BS, Inglese G, Eaves D, Oster G. Risk and economic burden of peristomal skin complications following ostomy surgery. J Wound Ostomy Continence Nurs. 2019;46(2):143. Plonkowski A, Allison C, Philipson P, Brady RR. Risk factors associated with readmission within 30 days following stoma surgery: development of a “traffic light” prediction model. Colorectal Dis. 2023;25(4):747–756. Chen SY, Stem M, Cerullo M, et al. Predicting the risk of readmission from dehydration after ileostomy formation: the DRIP score. Dis Colon Rectum. 2018;61(12):1410. Justiniano CF, Temple LK, Swanger AA, et al. Readmissions with dehydration after ileostomy creation: rethinking risk factors. Dis Colon Rectum. 2018;61(11):1297. Seo Y-J, Bailey K, Aguayo E, et al. Readmissions after ileostomy creation using a nationwide database. Am Surg. 2018;84(10):1661–1664. Sanaiha Y, Xing H, Morchi R, Seo YJ, Rudasill S, Benharash P. National study of immediate and delayed readmissions after colostomy creation. J Surg Res. 2020;246:457–463. Cox J, Isip R, Reid M, Hulme D, Marra A. Predictors of hospital readmission in patients undergoing creation of an intestinal ostomy. J Wound Ostomy Continence Nurs. 2023;50(3):215–221. Bliss LA, Maguire LH, Chau Z, et al. Readmission after resections of the colon and rectum: predictors of a costly and common outcome. Dis Colon Rectum. 2015;58(12):1164. Nagle D, Pare T, Keenan E, Marcet K, Tizio S, Poylin V. Ileostomy pathway virtually eliminates readmissions for dehydration in new ostomates. Dis Colon Rectum. 2012;55(12):1266–1272. Paquette IM, Solan P, Rafferty JF, Ferguson MA, Davis BR. Readmission for dehydration or renal failure after ileostomy creation. Dis Colon Rectum. 2013;56(8):974–979. R Foundation for Statistical Computing. R: a language and environment for statistical computing. https://www.R-project.org . Accessed December 12, 2022. National Health Service. National cost collection for the NHS. https://www.england.nhs.uk/costing-in-the-nhs/national-cost-collection . Accessed August 8, 2022. National Institute for Health and Care Excellence. Diverticular disease: diagnosis and management. NICE guideline [NG147]. https://www.nice.org.uk/guidance/NG147 . Accessed September 7, 2022. National Institute for Health and Care Excellence. NICE guideline NG147: economic analysis report. https://www.nice.org.uk/guidance/ng147/evidence/appendix-2-costeffective-analysis-laparoscopic-lavage-versus-resection-for-perforated-diverticulitis-pdf-250887833208 . Accessed September 7, 2022. North Bristol NHS Trust. Creatinine. https://www.nbt.nhs.uk/severn-pathology/requesting/test-information/creatinine . Accessed July 22, 2022. Hardiman KM, Reames CD, McLeod MC, Regenbogen SE. Patient autonomy–centered self-care checklist reduces hospital readmissions after ileostomy creation. Surgery. 2016;160(5):1302–1308. Thorpe G, Arthur A, McArthur M. Adjusting to bodily change following stoma formation: a phenomenological study. Disabil Rehabil. 2016;38(18):1791–1802. National Institute for Health and Care Excellence. NICE real-world evidence framework. https://www.nice.org.uk/corporate/ecd9/chapter/overview . Accessed December 12, 2022. National Institute for Health and Care Excellence. Home care for older people. https://www.nice.org.uk/guidance/qs123 . Accessed July 22, 2022. National Health Service. Colostomy. https://www.nhs.uk/conditions/colostomy . Accessed July 22, 2022. |
| تواريخ الأحداث: | Date Created: 20231115 Date Completed: 20240214 Latest Revision: 20240416 |
| رمز التحديث: | 20240417 |
| DOI: | 10.1097/WON.0000000000001028 |
| PMID: | 37966075 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1528-3976 |
|---|---|
| DOI: | 10.1097/WON.0000000000001028 |